Use of Activated Recombinant Human Factor VII in Cardiac Surgery

PHASE2TerminatedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Acquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary Bypass
Interventions
DRUG

activated recombinant human factor VII

Trial Locations (63)

1209

Novo Nordisk Investigational Site, Capital Federal

2000

Novo Nordisk Investigational Site, Rosario

2100

Novo Nordisk Investigational Site, København Ø

2195

Novo Nordisk Investigational Site, Johannesburg

3400

Novo Nordisk Investigational Site, Corrientes

4001

Novo Nordisk Investigational Site, Durban

7550

Novo Nordisk Investigational Site, Cape Town

10117

Novo Nordisk Investigational Site, Berlin

10461

Novo Nordisk Investigational Site, The Bronx

10467

Novo Nordisk Investigational Site, The Bronx

13210

Novo Nordisk Investigational Site, Syracuse

17821

Novo Nordisk Investigational Site, Danville

20097

Novo Nordisk Investigational Site, San Donato Milanese (MI)

20132

Novo Nordisk Investigational Site, Milan

21287

Novo Nordisk Investigational Site, Baltimore

23298

Novo Nordisk Investigational Site, Richmond

23507

Novo Nordisk Investigational Site, Norfolk

28006

Novo Nordisk Investigational Site, Madrid

28034

Novo Nordisk Investigational Site, Madrid

28046

Novo Nordisk Investigational Site, Madrid

30322

Novo Nordisk Investigational Site, Atlanta

35235

Novo Nordisk Investigational Site, Birmingham

40138

Novo Nordisk Investigational Site, Bologna

41013

Novo Nordisk Investigational Site, Seville

44093

Novo Nordisk Investigational Site, Nantes

44195

Novo Nordisk Investigational Site, Cleveland

47805

Novo Nordisk Investigational Site, Krefeld

48013

Novo Nordisk Investigational Site, Bilbao

50400

Novo Nordisk Investigational Site, Kuala Lumpur

50924

Novo Nordisk Investigational Site, Cologne

52074

Novo Nordisk Investigational Site, Aachen

54511

Novo Nordisk Investigational Site, Vandœuvre-lès-Nancy

60590

Novo Nordisk Investigational Site, Frankfurt/M.

73117

Novo Nordisk Investigational Site, Oklahoma City

77030

Novo Nordisk Investigational Site, Houston

80262

Novo Nordisk Investigational Site, Denver

80636

Novo Nordisk Investigational Site, München

85714

Novo Nordisk Investigational Site, Tucson

89075

Novo Nordisk Investigational Site, Ulm

94115

Novo Nordisk Investigational Site, San Francisco

97207

Novo Nordisk Investigational Site, Portland

110025

Novo Nordisk Investigational Site, New Delhi

168752

Novo Nordisk Investigational Site, Singapore

600101

Novo Nordisk Investigational Site, Chennai

02215

Novo Nordisk Investigational Site, Boston

08103

Novo Nordisk Investigational Site, Camden

C1181ACH

Novo Nordisk Investigational Site, Buenos Aires

C1093AAS

Novo Nordisk Investigational Site, Caba

05403-000

Novo Nordisk Investigational Site, São Paulo

04289

Novo Nordisk Investigational Site, Leipzig

560 099

Novo Nordisk Investigational Site, Bangalore

600 037

Novo Nordisk Investigational Site, Chennai

695 011

Novo Nordisk Investigational Site, Trivendrum

00149

Novo Nordisk Investigational Site, Roma

00161

Novo Nordisk Investigational Site, Roma

08035

Novo Nordisk Investigational Site, Barcelona

221 85

Novo Nordisk Investigational Site, Lund

CB3 8RE

Novo Nordisk Investigational Site, Cambridge

LE3 9QP

Novo Nordisk Investigational Site, Leicester

EC1A 7BE

Novo Nordisk Investigational Site, London

SW3 6NP

Novo Nordisk Investigational Site, London

W1G 8PH

Novo Nordisk Investigational Site, London

SO16 6YD

Novo Nordisk Investigational Site, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY